Lanzieri Tatiana M, Kruszon-Moran Deanna, Amin Minal M, Bialek Stephanie R, Cannon Michael J, Carroll Margaret D, Dollard Sheila C
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland, USA.
Clin Vaccine Immunol. 2015 Feb;22(2):245-7. doi: 10.1128/CVI.00697-14. Epub 2014 Dec 17.
Cytomegalovirus (CMV) seroprevalence among U.S. children 1 to 5 years old was assessed in the National Health and Nutrition Examination Survey of 2011 to 2012. The overall seroprevalence (95% confidence interval) of IgG was 20.7% (14.4 to 28.2%), that of IgM was 1.1% (0.4 to 2.4%), and that of low IgG avidity was 3.6% (1.7 to 6.6%), corresponding to a 17.3% (10.1 to 26.7%) prevalence of recent infection among IgG-positive children.
在2011年至2012年的美国国家健康与营养检查调查中,对1至5岁美国儿童的巨细胞病毒(CMV)血清阳性率进行了评估。IgG的总体血清阳性率(95%置信区间)为20.7%(14.4%至28.2%),IgM为1.1%(0.4%至2.4%),低IgG亲和力为3.6%(1.7%至6.6%),这相当于IgG阳性儿童中近期感染的患病率为17.3%(10.1%至26.7%)。